Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(14)70013-x ◽

2014 ◽

Vol 2 (4) ◽

pp. 293-300 ◽

Author(s):

Andrew R Goudie ◽

Brian J Lipworth ◽

Pippa J Hopkinson ◽

Li Wei ◽

Allan D Struthers

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30102-4 ◽

2018 ◽

Vol 6 (5) ◽

pp. 337-344 ◽

Author(s):

Peter M A Calverley ◽

Antonio R Anzueto ◽

Kerstine Carter ◽

Lars Grönke ◽

Christoph Hallmann ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Faculty Opinions recommendation of Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732949526.793564094 ◽

2019 ◽

Author(s):

Mario Cazzola

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Download Full-text

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Download Full-text

Correction: Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0152379 ◽

2016 ◽

Vol 11 (3) ◽

pp. e0152379

Author(s):

Genfa Wang ◽

Baojun Liu ◽

Yuxue Cao ◽

Yijie Du ◽

Hongying Zhang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Randomized Controlled Trial ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Randomized Controlled ◽

Chinese Herbal ◽

Herbal Formulae

Download Full-text

A multicenter randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of rhubarb in treating acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2016.07.002 ◽

2016 ◽

Vol 3 (2) ◽

pp. 71-80

Author(s):

Fengjie Zheng ◽

Yan Sun ◽

Xianggen Zhong ◽

Yueqi Wang ◽

Ruohan Wu ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Doxycycline for outpatient-treated acute exacerbations of Chronic obstructive pulmonary disease (COPD): a randomized double-blind placebo-controlled trial

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2017.08.080 ◽

2017 ◽

Vol 53 (4) ◽

pp. 597

Author(s):

Krysia Crabtree

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

Acute Exacerbations

Download Full-text

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70052-3 ◽

2013 ◽

Vol 1 (3) ◽

pp. 199-209 ◽

Author(s):

Jadwiga A Wedzicha ◽

Marc Decramer ◽

Joachim H Ficker ◽

Dennis E Niewoehner ◽

Thomas Sandström ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Parallel Group Study ◽

Download Full-text